DNA-only, microwell-based bioassay for multiplex nucleic acid detection with single base-pair resolution using MNAzymes. Safdar S, Ven K, Van L, Pavie B, Rutten I, Dillen A, Munck S, Lammertyn J, Spasic D BIOSENS BIOELECTRON 112017 152 2020 DOI 10.1016/j.bios.2020.112017 Nose-to-brain delivery of enveloped RNA - cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases. Samaridou E, Walgrave H, Salta E, Alvarez D, Castro-lopez V, Loza M, Alonso M Biomaterials 119657 230 2020 DOI 10.1016/j.biomaterials.2019.119657 Brain Volume: An Important Determinant of Functional Outcome After Acute Ischemic Stroke. Schirmer M et al MAYO CLIN PROC 955-965 95 2020 DOI 10.1016/j.mayocp.2020.01.027 Collaborating by courier, imaging by mail. Schweigreiter R, Cawthorne C, Lippens S, Van Minnebruggen G, Munck S@ EMBO REP e49755 21 2020 DOI 10.15252/embr.201949755 Inflammatory aortitis in a patient with type 2 hyper IgM syndrome. Staels F@, Betrains A, Willemsen M, Corvelyn A, Tousseyn T, Dierickx D, Humblet-Baron S, Liston A, Vanderschueren S, Schrijvers R RHEUMATOLOGY 2020 DOI 10.1093/rheumatology/keaa573 Diagnostic yield of testing for RFC1 repeat expansions in patients with unexplained adult-onset cerebellar ataxia. Van Daele S, Vermeer S, Van E, Lannoo L, Race V, Van Damme P, Claeys K, Vandenberghe W J Neurol Neurosur Psych 1233-1234 91 2020 DOI 10.1136/jnnp-2020-323998 Necrosome-positive granulovacuolar degeneration is associated with TDP-43 pathological lesions in the hippocampus of ALS/FTLD cases. Van Schoor E, Koper M, Ospitalieri S, Dedeene L, Tome S, Vandenberghe R, Brenner D, Otto M, Weishaupt J, Ludolph A, Van Damme P, Van Den Bosch L, Thal D NEUROPATHOL APPL NEUROBIOL 2020 DOI 10.1111/nan.12668 Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics. Van W, Devrome M, Schramm G, De Vocht J, Deckers W, Baete K, Van Damme P, Koole M, Van L EUR J NUCL MED MOL IMAGING 2020 DOI 10.1007/s00259-020-04786-y Moving towards multicenter therapeutic trials in ALS: feasibility of data pooling using different TSPO positron emission tomography (PET) radioligands. Van W, Babu S, De Vocht J, Zurcher N, Chew S, Tseng C, Loggia M, Koole M, Rezaei A, Schramm G, Van Damme P, Hooker J, Van L, Atassi N J NUCL MED 2020 DOI 10.2967/jnumed.119.241059 Functional expression and pharmacological modulation of TRPM3 in human sensory neurons. Vangeel L, Benoit M, Miron Y, Miller P, De Clercq K, Chaltin P, Verfaillie C, Vriens J, Voets T@ BRIT J PHARMACOL 2683-2695 177 2020 DOI 10.1111/bph.14994 Pagination Previous page ‹ Previous Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 Next page Next ›
DNA-only, microwell-based bioassay for multiplex nucleic acid detection with single base-pair resolution using MNAzymes. Safdar S, Ven K, Van L, Pavie B, Rutten I, Dillen A, Munck S, Lammertyn J, Spasic D BIOSENS BIOELECTRON 112017 152 2020 DOI 10.1016/j.bios.2020.112017
Nose-to-brain delivery of enveloped RNA - cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases. Samaridou E, Walgrave H, Salta E, Alvarez D, Castro-lopez V, Loza M, Alonso M Biomaterials 119657 230 2020 DOI 10.1016/j.biomaterials.2019.119657
Brain Volume: An Important Determinant of Functional Outcome After Acute Ischemic Stroke. Schirmer M et al MAYO CLIN PROC 955-965 95 2020 DOI 10.1016/j.mayocp.2020.01.027
Collaborating by courier, imaging by mail. Schweigreiter R, Cawthorne C, Lippens S, Van Minnebruggen G, Munck S@ EMBO REP e49755 21 2020 DOI 10.15252/embr.201949755
Inflammatory aortitis in a patient with type 2 hyper IgM syndrome. Staels F@, Betrains A, Willemsen M, Corvelyn A, Tousseyn T, Dierickx D, Humblet-Baron S, Liston A, Vanderschueren S, Schrijvers R RHEUMATOLOGY 2020 DOI 10.1093/rheumatology/keaa573
Diagnostic yield of testing for RFC1 repeat expansions in patients with unexplained adult-onset cerebellar ataxia. Van Daele S, Vermeer S, Van E, Lannoo L, Race V, Van Damme P, Claeys K, Vandenberghe W J Neurol Neurosur Psych 1233-1234 91 2020 DOI 10.1136/jnnp-2020-323998
Necrosome-positive granulovacuolar degeneration is associated with TDP-43 pathological lesions in the hippocampus of ALS/FTLD cases. Van Schoor E, Koper M, Ospitalieri S, Dedeene L, Tome S, Vandenberghe R, Brenner D, Otto M, Weishaupt J, Ludolph A, Van Damme P, Van Den Bosch L, Thal D NEUROPATHOL APPL NEUROBIOL 2020 DOI 10.1111/nan.12668
Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics. Van W, Devrome M, Schramm G, De Vocht J, Deckers W, Baete K, Van Damme P, Koole M, Van L EUR J NUCL MED MOL IMAGING 2020 DOI 10.1007/s00259-020-04786-y
Moving towards multicenter therapeutic trials in ALS: feasibility of data pooling using different TSPO positron emission tomography (PET) radioligands. Van W, Babu S, De Vocht J, Zurcher N, Chew S, Tseng C, Loggia M, Koole M, Rezaei A, Schramm G, Van Damme P, Hooker J, Van L, Atassi N J NUCL MED 2020 DOI 10.2967/jnumed.119.241059
Functional expression and pharmacological modulation of TRPM3 in human sensory neurons. Vangeel L, Benoit M, Miron Y, Miller P, De Clercq K, Chaltin P, Verfaillie C, Vriens J, Voets T@ BRIT J PHARMACOL 2683-2695 177 2020 DOI 10.1111/bph.14994
